Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

0.4120

+0.0420 (11.35%)

At close: Apr 1, 2025, 4:00 PM

0.3956

-0.0164 (-3.98%)

After-hours: Apr 1, 2025, 5:06 PM EDT

Processa Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	4.78	5.66	8.76	4.69	3.26	Upgrade
Research & Development	7.27	5.8	11.49	6.88	3.17	Upgrade
Operating Expenses	12.05	11.46	20.26	11.57	6.44	Upgrade
Operating Income	-12.05	-11.46	-20.26	-11.57	-6.44	Upgrade
Interest Expense	-	-	-	-	-0.28	Upgrade
Interest & Investment Income	0.2	0.34	0.1	0.01	0	Upgrade
EBT Excluding Unusual Items	-11.85	-11.12	-20.16	-11.56	-6.71	Upgrade
Asset Writedown	-	-	-7.27	-	-	Upgrade
Other Unusual Items	-	-	-	0.16	-	Upgrade
Pretax Income	-11.85	-11.12	-27.42	-11.96	-15.41	Upgrade
Income Tax Expense	-	-	-	-0.53	-1	Upgrade
Net Income	-11.85	-11.12	-27.42	-11.43	-14.41	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	4.63	Upgrade
Net Income to Common	-11.85	-11.12	-27.42	-11.43	-19.04	Upgrade
Shares Outstanding (Basic)	3	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	3	1	1	1	0	Upgrade
Shares Change (YoY)	133.30%	62.83%	5.16%	104.27%	35.72%	Upgrade
EPS (Basic)	-3.87	-8.48	-34.05	-14.92	-50.77	Upgrade
EPS (Diluted)	-3.87	-8.48	-34.05	-14.92	-50.77	Upgrade
Free Cash Flow	-11.25	-8.07	-9.61	-8.72	-3.14	Upgrade
Free Cash Flow Per Share	-3.68	-6.15	-11.93	-11.38	-8.38	Upgrade
EBITDA	-12.05	-11.46	-19.47	-10.78	-5.63	Upgrade
D&A For EBITDA	0	0	0.79	0.79	0.8	Upgrade
EBIT	-12.05	-11.46	-20.26	-11.57	-6.44	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q